Odyssey Group International, Inc: Odyssey Group International/Prevacus, Inc. Reports Brain Bio-Distribution Findings of PRV-002
a nasally delivered drug in development for treating concussion, highlight rapid brain bioavailability
IRVINE, CA / ACCESSWIRE / February 17, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ( Odyssey ), a technology and asset acquisition company focused on developing unique, life-saving medical products, and Prevacus Inc., are pleased to report the results of pre-clinical studies related to brain biodistribution of PRV-002 (Prevasol), a novel compound in development for the treatment of concussion.
In this study, PRV-002, a neurosteroid, was formulated in its native form and as a nanoparticle. Pre-clinical animal studies of PRV-002 have shown rapid absorption in the brain with biodistribution across the entire brain when administered nasally.
Odyssey Group International/Prevacus, Inc Reports Brain Bio-Distribution Findings of PRV-002
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Odyssey Group International/Prevacus, Inc Reports Brain Bio-Distribution Findings of PRV-002
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
(1)
IRVINE, CA / ACCESSWIRE / February 9, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the Company or Odyssey ), a technology and asset acquisition company focused on developing unique, life-saving medical products, is pleased to announce multiple recent television segments focused on the development of a treatment for concussion by Prevacus , CEO Dr. Jake VanLandingham and Brett Favre. The appearances included:
CheddarTV s Closing Bell on Friday, February 5 (watch online)
Newsmax s National Report on Sunday, February 7 (watch online) and
Fox Business Kennedy Nation on Monday February 8 (watch online)
In addition, former NFL stars Kurt Warner and Mark Rypien discussed brain injuries and the Prevacus drug candidate on Fox News Fox and Friends on Saturday February 6 (watch online).